Your Elite Trading Review: Week of January 28

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Wall Street Insights & Indictments. Your ability to alter your subscription information can be found at the bottom of this email.

Two months, $24 million and counting (this is just the tip of the iceberg) Legal marijuana is practically minting money. In fact, since recreational marijuana shops opened in Massachusetts, they've racked up nearly $24 million in sales. As more and more states jump on the cannabis bandwagon, we could see this industry balloon into a TRILLION-dollar behemoth - and a single investment today could have the power to set you up for life. Take a look... February 3, 2019 Dear Wall Street Insights & Indictments Reader, It's February already. One year ago, February volatility jump-started the wild rollercoaster ride that was 2018. Are we in for it again? That remains to be seen. February's not just a rough month because we're yet again reminded of how ridiculous last year was. It's rough because, by now, 80% of folks have given up on their New Year's resolutions - whether it was to better their health, find a new career path, or make this the year that they pay off all their debt. That's just plain sad. There's no excuse for giving up on your dreams - especially ones that are as reachable as making money. You just have to know what advice to follow and who to look to. Enter my friend and colleague, America's #1 Pattern Trader Tom Gentile. Tom's personal resolution this year is to make sure that you have as many moneymaking opportunities as possible - and for you to achieve your wealth-building dreams. He's releasing five massive opportunities that you can act on right away, enough to give you the chance to become $15,000 wealthier right off the bat. Plus, he'll show you how you can set these up for life so you can be put on the path to riches - starting this year. Don't pass up the chance to make 2019 the year you can say, "I did it." Click here to learn more. Meanwhile, here's how our premium subscribers spent their week... Wall Street's Losers are the Best - Here's Why At Zenith Trading Circle, we do things a little differently. Rather than targeting companies that are set to soar, we target those of a different variety... The ones doomed to fail, the scorned, the pitiful. And we have a whole lot of fun doing it - to name a few, Zenith readers have had the opportunity to close out on 100% gains on Starbucks, 100% and 20% on each half of Dillard's, and 100% on one half of a Fitbit recommendation. With the market as crazy as it's been, you can be there will be more recommendations - and profit potential - like these in 2019... [Full Story] Long Live the Free Markets There's just no such thing anymore as "free markets." Wednesday's Federal Reserve "presser" was the nail in the coffin of free markets. It's not like we didn't already know markets were being manipulated right and left. It's just that the most powerful force in the world might have had enough respect for markets to not openly admit they were going to be manipulated when they didn't have to be. It's a tragic comedy, and the Master Algorithm has something to say about it... [Full Story] How We'll Seize the Chip Rebound Opportunity Over roughly the past year, Wall Street's been warning investors of a major slump in semiconductor sales. The feeling was that the boom in chips had peaked, and it was all downhill from there, and a lot of stocks were under pressure as a result. Meanwhile, Michael A. Robinson was one of the few analysts out there to say the sector was greatly oversold - and he has a very good reason for taking that position... [Full Story] This Cancer Fighter Just Opened Up Another Massive Market Cancer is one of the deadliest diseases known to man, with about 38.4% of people expected to be diagnosed with it at some point during their lifetime. Liver cancer rates, in particular, have tripled since 1980, and one of Michael A. Robinson's latest recommendation has created a drug to treat liver and kidney cancers, and the company could be well on its way for a price surge... [Full Story] If you're already a member of these research services, make sure you haven't missed any of these crucial email alerts. If you're not yet a member, you can click on any of the links above to find out how you can get these exclusive trade recommendations delivered right to your inbox every week. You'll gain immediate access to our premium research, and you'll receive our exclusive trade recommendations as soon as we see a window of opportunity. Sharing the most profitable trading strategies with everyday readers is what we do best, and I don't want anyone to miss out. Here's to even more profit potential this week! I'll be back with you soon. Sincerely, Shah Share This Article:

You are receiving this email at its028@gmail.com as a part of your free subscription to Wall Street Insights & Indictments. Remove your email from this list: Unsubscribe Manage Your Email Preferences To cancel by mail or for any other subscription issues, write us at: Wall Street Insights & Indictments | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050 Contact Customer Service Website: https://wallstreetinsightsandindictments.com/ © 2019 Wall Street Insights & Indictments All Rights Reserved. Copyright - 2019 Money Map Press, LLC. The Money Map Press is a publishing company that does not act as a personal investment advisor for any specific individual. Nor do we advocate the purchase or sale of any security or investment for any specific individual. The proprietary recommendations and analysis we present to readers is for the exclusive use of subscribers. Readers should be aware that although our track record is highly rated, and has been legally reviewed for presentation in this invitation, investment markets have inherent risks and there can be no guarantee of future profits. Likewise, past performance is not necessarily indicative of future results. Stocks, futures, currencies, commodities, CFDs, options and all types of investment trading can have large potential rewards, but also carry large potential risks. We make absolutely no representation that gains or losses demonstrated in services published by Money Map Press LLC are likely or achievable. Please Note: Any performance results described herein are not based on actual trading of securities but are instead based on a hypothetical trading account which entered and exited the suggested positions in securities at the times and prices referenced. Hypothetical performance results have many inherent limitations. In fact, there are frequently sharp differences between hypothetical performance results and the actual results that may subsequently be achieved. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk in actual trading. For example, hypothetical trading examples cannot possibly take into account the impact of liquidity or buyer and seller demand, and do not allow for slippage and associated trading costs and concerns. One must be aware of the risks and be willing to accept them in order to invest in the markets. One should never trade with money that one cannot afford to lose, and one must accept that there will be losses, and one must be able to sustain these losses, both from a financial as well as an emotional perspective. Recommendations are for the exclusive use of subscribers and can change at any time. This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Wall Street Insights & Indictments. 1125 N Charles Street, Baltimore MD 21201.